Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-Small Cell Lung Cancer, Head and Neck Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT06607185
What this trial is testing

The Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors

Who this might be right for
Pancreatic Ductal AdenocarcinomaNon-small Cell Lung CancerColorectal Cancer+2 more
Eli Lilly and Company 750
Not applicableStudy completedNCT00900302
What this trial is testing

OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer

Who this might be right for
Cancer
OHSU Knight Cancer Institute 98
Early research (Phase 1)Ended earlyNCT04187872
What this trial is testing

LITT and Pembrolizumab in Recurrent Brain Metastasis

Who this might be right for
MelanomaNon-small Cell Lung Carcinoma (NSCLC)Renal Cell Carcinoma (RCC)+12 more
University of Florida 10
Early research (Phase 1)Not Yet RecruitingNCT07814248
What this trial is testing

A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors

Who this might be right for
NSCLC (Non-small Cell Lung Cancer)HNSCCEndometrial+5 more
TwoStep Therapeutics, Inc. 74
Testing effectiveness (Phase 2)Study completedNCT01631552
What this trial is testing

Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer

Who this might be right for
Gastric AdenocarcinomaEsophageal CancerHepatocellular Carcinoma+13 more
Gilead Sciences 515
Early research (Phase 1)Study completedNCT03319459
What this trial is testing

FATE-NK100 as Monotherapy and in Combination With Monoclonal Antibody in Subjects With Advanced Solid Tumors

Who this might be right for
HER2 Positive Gastric CancerColorectal CancerHead and Neck Squamous Cell Carcinoma+8 more
Fate Therapeutics 44
Early research (Phase 1)UnknownNCT04660929
What this trial is testing

CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors

Who this might be right for
HER2-positiveAdenocarcinomaBile Duct Cancer+28 more
Carisma Therapeutics Inc 48
Early research (Phase 1)Ended earlyNCT04254107
What this trial is testing

A Safety Study of SEA-TGT (SGN-TGT) in Advanced Cancer

Who this might be right for
Non-small Cell Lung CancerGastric CarcinomaGastroesophageal Junction Carcinoma+9 more
Seagen Inc. 133
Early research (Phase 1)Ended earlyNCT00689065
What this trial is testing

Safety Study of CALAA-01 to Treat Solid Tumor Cancers

Who this might be right for
CancerSolid Tumor
Calando Pharmaceuticals 24
Early research (Phase 1)Looking for participantsNCT07348211
What this trial is testing

First in Human Study of SIM0610 in Solid Tumors

Who this might be right for
Advanced Solid TumoursNon-Small Cell Lung CancerColorectal Cancer+2 more
Jiangsu Simcere Pharmaceutical Co., Ltd. 260
Not applicableLooking for participantsNCT03948100
What this trial is testing

Dyadic Yoga Intervention in Improving Physical Performance and Quality of Life in Patients With Stage I-IV Non-small Cell Lung or Esophageal Cancer Undergoing Radiotherapy and Their Caregivers

Who this might be right for
Esophageal CarcinomaLung Non-Small Cell CarcinomaStage I Lung Cancer AJCC v8+14 more
M.D. Anderson Cancer Center 400
Early research (Phase 1)Study completedNCT00002901
What this trial is testing

Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function

Who this might be right for
Breast CancerHead and Neck CancerLung Cancer+2 more
City of Hope Medical Center
Early research (Phase 1)Study completedNCT04319757
What this trial is testing

ACE1702 in Subjects With Advanced or Metastatic HER2-expressing Solid Tumors

Who this might be right for
Locally Advanced Solid TumorMetastatic CancerSolid Tumor+2 more
Acepodia Biotech, Inc. 12
Early research (Phase 1)Ended earlyNCT05576077
What this trial is testing

TBio-4101 (TIL) and Pembrolizumab in Patients With Advanced Solid Tumors

Who this might be right for
Breast CancerColorectal CancerUveal Melanoma+3 more
Turnstone Biologics, Corp. 31
Not applicableStudy completedNCT00533884
What this trial is testing

Neurocognitive Functioning in Patients With Newly Diagnosed Upper Aerodigestive Tract Cancer Receiving Treatment at Henry-Joyce Cancer Clinic

Who this might be right for
Neurocognitive ImpairmentDeliriumEsophageal Cancer+2 more
Vanderbilt University Medical Center 86
Testing effectiveness (Phase 2)UnknownNCT05117138
What this trial is testing

Safety and Efficacy of Chimeric Antigen Receptor T Lymphocytes for Patients With Intermediate and Advanced Tumors

Who this might be right for
MelanomaNon-small Cell Lung CancerHead and Neck Squamous Cell Carcinoma
Beijing Immunochina Medical Science & Technology Co., Ltd. 39
Testing effectiveness (Phase 2)UnknownNCT05094804
What this trial is testing

OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents

Who this might be right for
CancerTumor, SolidMalignant Neoplasm+7 more
OncoResponse, Inc. 172
Early research (Phase 1)Active Not RecruitingNCT04603287
What this trial is testing

SI-B001, an EGFR/HER3 Bispecific Antibody, in Locally Advanced or Metastatic Epithelial Tumors

Who this might be right for
Locally Advanced or Metastatic Epithelial Tumor
Sichuan Baili Pharmaceutical Co., Ltd. 60
Not applicableStudy completedNCT02972216
What this trial is testing

Post-marketing Surveillance Study of Docetaxel-Based Chemotherapy

Who this might be right for
Nonsmall Cell Lung CancerSquamous Cell Carcinoma of the Head and Neck
Yung Shin Pharm. Ind. Co., Ltd. 40
Not applicableStudy completedNCT00957424
What this trial is testing

Acceptability of Less Harmful Alternatives to Cigarettes

Who this might be right for
Bladder CancerCervical CancerEsophageal Cancer+8 more
Roswell Park Cancer Institute 67
Next Page